Rocco Piazza
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 38
- Acute Myeloid Leukemia Research 17
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 29
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Rheumatology top 2%
- Eosinophilic Disorders and Syndromes 17
- Oncology top 10%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 12
-
- Lymphoma Diagnosis and Treatment 13
-
- Lung Cancer Treatments and Mutations 13
- Co-authors
- Carlo Gambacorti‐PasseriniLéonardo ScapozzaVera MagistroniSara RedaelliRoberta RostagnoAnnamaria GaliettaRosalind H. GunbyLuca Mologni
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Rocco Piazza
127 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 109
- Hematology 874
- Genetics 659
- Rheumatology 407
- Oncology 447
- Cancer Research 193
Countries citing papers authored by Rocco Piazza
This map shows the geographic impact of Rocco Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Piazza more than expected).
Fields of papers citing papers by Rocco Piazza
This network shows the impact of papers produced by Rocco Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Piazza. The network helps show where Rocco Piazza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rocco Piazza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 27 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 34 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 8 | |
| 18 | 2018 | 61 | |
| 19 | 2014 | 47 | |
| 20 | [Dimensions of the proximal thoracic aorta from childhood to adult age: reference values for two-dimensional echocardiography. Ligurian Group of SIEC (Italian Society of Echocardiography)]. | 1997 | 6 |
About Rocco Piazza
Rocco Piazza is a scholar working on Hematology, Genetics and Cancer Research, having authored 137 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (38 papers), Chronic Lymphocytic Leukemia Research (29 papers), Acute Myeloid Leukemia Research (17 papers), Eosinophilic Disorders and Syndromes (17 papers), Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). The work is most often cited by research in Hematology (874 citations), Genetics (659 citations) and Rheumatology (407 citations). Rocco Piazza has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Carlo Gambacorti‐Passerini, Léonardo Scapozza, Vera Magistroni, Sara Redaelli, Roberta Rostagno, Annamaria Galietta, Rosalind H. Gunby, Luca Mologni, Alessandra Pirola and Monica Ceccon. Their work appears in journals such as Blood, Cancers, American Journal of Hematology, Scientific Reports and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.